Conversations in Lung Cancer Research
Episodes
New and Emerging Practice Standards in ES-SCLC
11 Dec 2025
Contributed by Lukas
In this episode of 'Conversations in Lung Cancer Research,' host Dr. Rebecca Tay and fellow oncologists A/Prof Surein Arulananda and Dr. Dasantha Jaya...
Exploring Lung Cancer Care and Research in New Zealand
27 Nov 2025
Contributed by Lukas
his episode of 'Conversations in Lung Cancer Research' hosted by Dr Alex Davis, features a discussion with Dr. Laird Cameron and Dr. Annie Wong on the...
Challenging Ageism: Optimising Lung Cancer Treatment in Older Adults
02 Oct 2025
Contributed by Lukas
In this episode of Conversations in Lung Cancer Research, hosted by Dr Michael Krasovitsky, a medical oncologist at St. Vincent's Hospital in Sydney, ...
Prof. Anna Nowak: A Journey from Oncology Lab to Leadership
18 Sep 2025
Contributed by Lukas
In this episode of Conversations in Lung Cancer Research, host A/Prof Mel Moore interviews Prof Anna Nowak, a renowned medical oncologist, clinical tr...
CNS Progression in Lung Cancer: A Practical Conversation on Best Practices
04 Sep 2025
Contributed by Lukas
n this episode of Conversations in Lung Cancer Research, A/Prof Tim Clay discusses the multidisciplinary management of CNS metastases in the context o...
A/Prof Fiona Hegi Johnson: Navigating Careers and Innovations in Lung Cancer Research
14 Aug 2025
Contributed by Lukas
In this episode of 'Conversations in Lung Cancer Research,' A/Prof Mel Moore sits down with A/Prof Fiona Hegi Johnson, a radiation oncologist at the P...
Prof Shankar Siva: Pushing Boundaries in Radiation Oncology
10 Jul 2025
Contributed by Lukas
In this episode of TOGA's Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Shankar Siva about his groundbreaking work in radia...
The Emerging Role of the Microbiome in Lung Cancer and Immunotherapy Response
19 Jun 2025
Contributed by Lukas
This episode of 'Conversations in Lung Cancer Research' features Dr. Anna McLean, Dr Mark Adams, and Dr Sagun Parakh, discussing research on the micro...
Lessons from Fellowships and building Clinical Trials Units
05 Jun 2025
Contributed by Lukas
In this episode of Conversations in Lung Cancer Research, we welcome A/Prof Bryan Chan, a senior Medical Oncologist and this years TOGA ASM Convener. ...
Prof Wendy Cooper: Journey of a Thoracic Pathologist
21 May 2025
Contributed by Lukas
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore speaks with Prof Wendy Cooper, a leading pathologist in cancer research. Th...
Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy
08 May 2025
Contributed by Lukas
In this episode of 'Conversations in Lung Cancer Research,' Professor Tom John from the Peter MacCallum Cancer Centre in Melbourne discusses the signi...
The Role of Liquid Biopsy in Modern Oncology
20 Mar 2025
Contributed by Lukas
In this episode of Conversations in Lung Cancer Research, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Stephen Kao discuss the concept of liquid bi...
Exploring EGFR Exon 20 Insertion Mutations
06 Mar 2025
Contributed by Lukas
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arul...
From Clinical Research to Leadership: A Conversation with Prof. Michael Boyer
05 Feb 2025
Contributed by Lukas
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical onc...
Introducing Conversations in Lung Cancer Research - Trailer
04 Feb 2025
Contributed by Lukas
In this introductory episode, Associate Professor Mel Moore, medical oncologist and education chair at TOGA, announces the evolution of TOGA podcasts ...
Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy
12 Dec 2024
Contributed by Lukas
We have witnessed incredible advances in therapy since ALK was discovered in 2007, starting from the pivotal PROFILE 1001 study of crizotinib in advan...
Hit It With Your Best Shot- The Case for IO in Early-Stage NSCLC in a Once in a Lifetime World
02 Dec 2024
Contributed by Lukas
Large-Cell Neuroendocrine Carcinoma of the Lung (LCNEC): Challenges in Diagnosis and Treatment
14 Nov 2024
Contributed by Lukas
In this episode, we discuss the clinical and diagnostic markers when identifying a rare sub type of NSCLC, large-cell neuroendocrine carcinomas (LC-NE...
Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)
30 Sep 2024
Contributed by Lukas
NTRK1, 2,3 And Other Rare Mutations In NSCLC
30 Aug 2024
Contributed by Lukas
In this TOGA podcast, we provide an overview of the treatment options for rare subtypes of oncogene driven NSCLC that are now readily identified in th...
Decoding Perioperative Immunotherapy In NSCLC
25 Jul 2024
Contributed by Lukas
In this TOGA podcast, we provide an overview of the recent neoadjuvant, adjuvant, and perioperative IO data, the options and considerations for treatm...
Access to New Medicines: Which Surrogate Endpoints Matter
19 Jun 2024
Contributed by Lukas
Do we need to evolve the bar on evidence required for drug reimbursement? The gold standard endpoint for assessing the benefit of anti-cancer drugs ha...
Lung Cancer Nurses: Essential, Beneficial and a Key Link In Lung Cancer Screening
22 Apr 2024
Contributed by Lukas
Lung Cancer Support Nurse - Lung Foundation AustraliaQuit Centre | HomepageLung Cancer Screening Program: Early Detection Saves Lives (thoraciconcolog...
Underutilisation of Radiotherapy in Lung Cancer Treatment
27 Mar 2024
Contributed by Lukas
Radiation therapy can be a very effective treatment for lung cancers, with 77% of patients indicating for radiation therapy in their disease trajector...
Revolutionising Lung Cancer Healthcare with AI: Unlocking the Future
28 Feb 2024
Contributed by Lukas
Artificial intelligence (AI) is transforming medicine. Lung Cancer healthcare professionals are interested in the use of AI in radiology, particularly...
Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer
15 Dec 2023
Contributed by Lukas
In this TOGA Podcast the speakers discuss Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer. The discussion explores ...
Lung cancer Screening and Moving from Concept to Roll Out
31 Oct 2023
Contributed by Lukas
This TOGA Podcast discusses Lung cancer Screening and Moving from Concept to Roll Out. The conversation explores the International Lung Cancer Screen...
Early Recovery After Surgery - Guidelines and Multidisciplinary Considerations
06 Oct 2023
Contributed by Lukas
This TOGA Podcast discusses strategies for enhancing patients’ recovery from lung cancer resection in light of new and emerging data for new peri-op...
Nature and nurture: lung cancer risk and implications for future screening
10 Aug 2023
Contributed by Lukas
This TOGA Podcast discusses the data surrounding air pollution and lung cancer. The discussion delves into Nature and nurture and lung cancer risk and...
Operability in Stage III NSCLC
04 Jul 2023
Contributed by Lukas
In this TOGA Podcast, we discuss what defines operability in locally advanced stage III NSCLC. A/Professor Tim Clay, Medical Oncologist from St John o...
NSCLC and KRAS Mutations
06 Jun 2023
Contributed by Lukas
In this TOGA Podcast, Australian medical oncologist, Associate Professor Chee Lee, St George Hospital, Kogarah, is joined by medical oncologist Dr Tri...
Treatment Considerations in ALK-Positive NSCLC
21 Apr 2023
Contributed by Lukas
In this TOGA Podcast, Australian medical oncologist Dr Jenny Lee at Chris O’Brien Lifehouse, Sydney, is joined by medical oncologist Professor Nick ...
Celebrating Female Leadership in Medical Research
08 Mar 2023
Contributed by Lukas
In this TOGA Podcast, and on International Women’s Day 2023, we celebrate female leadership in medical research. We explore the challenges and succe...
Brain metastases in NSCLC
23 Feb 2023
Contributed by Lukas
Recent studies in NSCLC patients with ALK or EGFR mutations and brain metastases, demonstrated greater benefit from the use of specific targeted thera...
NGS panels in lung cancer
20 Dec 2022
Contributed by Lukas
In this Podcast, Dr Malinda Itchins, Medical Oncologist at Royal North Shore Hospital, Co-Chair of the Advanced Non-Small Cell Lung Cancer Group for T...
Lung Cancer Screening and its impact on patient care in Australia
07 Dec 2022
Contributed by Lukas
In the latest TOGA Podcast, Gavin Wright discusses Lung Cancer Screening and its impact on patient care in Australia, accessibility and practicalities...
The Management of Stage III NSCLC
31 Oct 2022
Contributed by Lukas
Welcome to the Thoracic Oncology Group of Australasia Podcast series. Associate Professor Shankar Siva, Radiation Oncologist and current Cancer Counci...
The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations
12 Oct 2022
Contributed by Lukas
Welcome to the Thoracic Oncology Group of Australasia Podcast series. In this Podcast, we discuss early NSCLC management and treatment, particularly i...
Cardiotoxicity and Radiation Therapy - Considerations for Lung Cancer
01 Sep 2022
Contributed by Lukas
For lung cancer patients, the benefits of treatment and potential for cure must always be balanced with risk. Cardiotoxicity is considered a short and...
Accelerating Progress in Oncogene-driven Lung Cancer
09 Aug 2022
Contributed by Lukas
Deme Karikios, Medical Oncologist and Director of Clinical trials at Nepean Cancer Care Centre in Sydney is joined by Wanda Cui, Medical Oncologist fr...
Access to Molecular Diagnostics and Treatments Across ANZ: The Past, Present, Future
24 Jul 2022
Contributed by Lukas
The identification of molecular subtypes of non-squamous NSCLC continues to grow, spurring the development of targeted therapies designed to target th...
Practical smoking cessation advice for health care providers
30 May 2022
Contributed by Lukas
In this TOGA Podcast, we discuss smoking cessation in the face of smoking-related stigma and nihilism. Dr Henry Marshall, Associate Professor and Clin...
Consider Every Trial as a TeleTrial
30 Apr 2022
Contributed by Lukas
Barriers and facilitators and a unique insight into the patient benefits are discussed between Alexandra, patient advocate, teletrials participant and...
EGFR Update: Improving Outcomes in EGFR-Mutated Non-Small-Cell Cancer
29 Mar 2022
Contributed by Lukas
Welcome to the Thoracic Oncology Group of Australasia Podcast series. Today Rachel Roberts-Thomson, Medical Oncologist from Queen Elizabeth Hospital ...
The need for a National Clinical Quality Registry in Lung Cancer
22 Feb 2022
Contributed by Lukas
The first TOGA Podcast for 2022 is about the need for a national clinical quality registry in lung cancer. A/Professor Emily Stone, the Deputy Chair ...
ALK treatment considerations in NSCLC
08 Dec 2021
Contributed by Lukas
Welcome to the Thoracic Oncology Group of Australasia Podcast series. Today Mal Itchins, Medical Oncologist from Royal North Shore Hospital discusses ...
Stigma and Nihilism In Lung Cancer : A Call to Action
23 Nov 2021
Contributed by Lukas
In this TOGA Podcast and in recognising Lung Cancer Awareness month 2021, Mel Moore, TOGA Education Chair and Medical Oncologist at St Vincent’s Hos...
Challenging the Lung Cancer Stigma
08 Nov 2021
Contributed by Lukas
In this Podcast, Briony Scott discusses the stigma often associated with a diagnosis of lung cancer with Danielle and Terri – both diagnosed with lu...
The Value of Comprehensive Genomic Profiling in Lung Cancer
17 Oct 2021
Contributed by Lukas
Drugs that target cancer gene mutations or rearrangements have improved outcomes for patients with many different cancers, including lung cancer, mela...
Inflammation And Its Impact On The Development & Treatment Of Lung Cancer
24 Sep 2021
Contributed by Lukas
Inflammation plays an important role in pathogenesis, development and progression of lung cancer. Widespread literature exists on the prognostic impac...
Optimising Diagnosis & Treatment Pathways For Lung Cancer Patients
30 Jul 2021
Contributed by Lukas
Delays in diagnosis are one of the main factors associated with reduced survival rates for lung cancer patients. Clinical guidelines have been impleme...
Long Term Survivorship: Thriving with Metastatic Lung Cancer
24 Jun 2021
Contributed by Lukas
Welcome to the Thoracic Oncology Group of Australasia Podcast series. This TOGA Podcast focuses on thriving with lung cancer and overcoming the chall...
Women and Lung Cancer: The Rising Tide
14 May 2021
Contributed by Lukas
Cigarette smoking is by far the greatest cause for lung cancer. But the proportion of lung cancer in patients who have never smoked before is on the r...
Practical Perspectives: Shifting the Needle in Small Cell Lung Canceer
01 Apr 2021
Contributed by Lukas
Welcome to the Thoracic Oncology Group of Australasia Podcast series. This TOGA Podcast focuses on Small Cell Lung cancer (SCLC) – a type of lung ca...
Lung cancer screening works!
01 Mar 2021
Contributed by Lukas
Lung cancer screening works. Earlier detection of lung cancer presents a vastly different prognosis. Stage I disease has a median 5 year survival of ...
Dreaming of Better Treatments for Mesothelioma
16 Feb 2021
Contributed by Lukas
Australia has one of the highest incidence rates of mesothelioma in the world.Mesothelioma is a form of cancer that most often affects the thin lining...
Lung Cancer Careers: Preceptorship Reflections
13 Dec 2020
Contributed by Lukas
The first virtual TOGA Preceptorship enabled 38 Preceptees involving Fellows, Advanced Trainees, Nurses and Patients to come together and discuss the ...
Cancer won't wait: A Cancer Australia Perspective
25 Nov 2020
Contributed by Lukas
Dorothy Keefe, CEO of Cancer Australia and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients – a 4 week delay in d...
2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer
18 Nov 2020
Contributed by Lukas
Remarkable advances in screening, diagnosing and treating lung cancer are discussed in this Podcast. Associate Professor Nick Pavlakis, Medical Oncolo...
Redefining Survival In Lung Cancer: Meet Alexandra
10 Nov 2020
Contributed by Lukas
Lung cancer is the leading cause of cancer related deaths in Australia, and lung cancer in never smokers is still the seventh leading cause of death. ...
Improving Survival In Oncogene Driven Lung Cancer
10 Nov 2020
Contributed by Lukas
Join us for a conversation with internationally recognized Medical Oncologists and researchers, Professor Ben Solomon & Associate Professor Tom John a...